Tempest Therapeutics, Inc. (TPST) has 8 open-market insider trades by 7 insiders since 2022. The most active filer is Samuel Whiting, Chief Medical Officer.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Thomas Woiwode | Dir10% Owner | — | 1 | $10.0M | 2022-04-29 |
| Versant Venture Capital VI, L.P. | 10% Owner | — | 1 | $1.4M | 2024-08-12 |
| Matthew Angel | CEOPres10% Owner | — | 1 | $500K | 2026-03-24 |
| Stephen R. Brady | CEOPres | — | 1 | $74K | 2024-07-03 |
| Samuel Whiting | Chief Medical Officer | — | 2 | $18K | 2024-07-02 |
| Justin Trojanowski | Controller | — | 1 | $16K | 2024-06-28 |
| Thomas W. Dubensky | Pres | — | 1 | $10K | 2022-01-07 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Matthew Angel | CEO & President +1 | Buy | $500K | 2026-03-24 |
| Versant Venture Capital VI, L.P. | 10% Owner | Sell | $1.4M | 2024-08-08 |
| Stephen R. Brady | CEO & President | Buy | $74K | 2024-07-03 |
| Samuel Whiting | Chief Medical Officer | Buy | $10K | 2024-07-02 |
| Justin Trojanowski | Controller | Buy | $16K | 2024-06-28 |
| Thomas Woiwode | Director & 10% Owner | Buy | $10.0M |
Companies that share insiders with TPST, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2022-04-29 |
| Thomas W. Dubensky | President | Buy | $10K | 2022-01-07 |
| Samuel Whiting | Chief Medical Officer | Buy | $8K | 2022-01-06 |